William W. Burke Sells 1,100 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) Stock

Tactile Systems Technology, Inc. (NASDAQ:TCMDGet Rating) Director William W. Burke sold 1,100 shares of the company’s stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $10.12, for a total transaction of $11,132.00. Following the sale, the director now owns 19,536 shares of the company’s stock, valued at $197,704.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of TCMD stock traded down $0.04 on Monday, hitting $9.50. The stock had a trading volume of 747,864 shares, compared to its average volume of 229,623. Tactile Systems Technology, Inc. has a 12-month low of $9.48 and a 12-month high of $57.64. The business has a 50 day moving average of $16.86 and a 200 day moving average of $18.46. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.56 and a quick ratio of 2.08. The stock has a market cap of $189.42 million, a price-to-earnings ratio of -7.54 and a beta of 1.40.

Tactile Systems Technology (NASDAQ:TCMDGet Rating) last announced its earnings results on Tuesday, February 22nd. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.34). The company had revenue of $61.73 million for the quarter, compared to the consensus estimate of $58.22 million. Tactile Systems Technology had a negative net margin of 11.78% and a negative return on equity of 12.31%. During the same quarter in the previous year, the firm earned $0.61 earnings per share. As a group, research analysts expect that Tactile Systems Technology, Inc. will post -0.49 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in the stock. Marshall Wace North America L.P. bought a new position in Tactile Systems Technology during the 1st quarter valued at about $25,000. PNC Financial Services Group Inc. lifted its stake in Tactile Systems Technology by 219.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,016 shares of the company’s stock valued at $40,000 after acquiring an additional 1,385 shares during the period. Advisor Group Holdings Inc. lifted its stake in Tactile Systems Technology by 20.3% during the 3rd quarter. Advisor Group Holdings Inc. now owns 2,546 shares of the company’s stock valued at $113,000 after acquiring an additional 429 shares during the period. KBC Group NV lifted its stake in Tactile Systems Technology by 315.7% during the 3rd quarter. KBC Group NV now owns 2,939 shares of the company’s stock valued at $131,000 after acquiring an additional 2,232 shares during the period. Finally, Banque Cantonale Vaudoise purchased a new stake in shares of Tactile Systems Technology during the 1st quarter valued at about $81,000. Institutional investors own 92.58% of the company’s stock.

TCMD has been the subject of several research reports. BTIG Research reduced their target price on shares of Tactile Systems Technology from $44.00 to $29.00 in a research note on Wednesday, February 23rd. StockNews.com began coverage on shares of Tactile Systems Technology in a research report on Thursday, March 31st. They issued a “hold” rating for the company. TheStreet lowered shares of Tactile Systems Technology from a “c-” rating to a “d” rating in a report on Wednesday, February 23rd. Finally, Piper Sandler dropped their price objective on shares of Tactile Systems Technology from $40.00 to $28.00 in a report on Wednesday, February 23rd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $38.00.

Tactile Systems Technology Company Profile (Get Rating)

Tactile Systems Technology, Inc, a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

Further Reading

Insider Buying and Selling by Quarter for Tactile Systems Technology (NASDAQ:TCMD)

Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.